Welcome To The Forum

GlobalData's pharmaceuticals report, "Lyxumia (Type 2 Diabetes) - Analysis and Forecasts to 2020" provides Lyxumia sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Type 2 Diabetes market. This report is built using data and information sourced from GlobalData's proprietary databases, primary and secondary research using Company's corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

http://www.fastmr.com/prod/235983_lyxumia_type_2_diabetes_analysis_and_forecasts_to.aspx